Results 151 to 160 of about 20,060 (180)

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study

Lancet, The, 2014
Eric Lawitz, Mark S Sulkowski, Zobair M Younossi   +2 more
exaly  

Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial

Lancet, The, 2014
Michael Manns, Maria Buti, Ewa Janczewska   +2 more
exaly  

Pegylated Interferon vs Standard Interferon for Chronic Hepatitis C

JAMA, 2005
openaire   +2 more sources

Pegylated Interferons

2006
openaire   +1 more source

[Pegylated interferons: pharmacological basis].

Gastroenterologie clinique et biologique, 2002
Isabelle, Macquin-Mavier, Christophe, Hezode, Daniel, Dhumeaux   +2 more
openaire   +1 more source

Pegylated Interferon Alpha-2b☆

2007
openaire   +1 more source

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial

Lancet, The, 2014
Gregory J Dore, Graham R Foster, Michael W Fried   +2 more
exaly  

Consensus + pegylated interferon

2003
openaire   +1 more source

Pegylated interferon alpha 2a versus pegylated interferon alpha 2b for chronic hepatitis C

2009
Awad, Tahany, Thorlund, Kristian, Hauser, Goran, Mabrouk, Mahasen, Stimac, Davor, Gluud, Christian   +5 more
openaire   +2 more sources

Pegylated interferon α-2b/ribavirin

Reactions Weekly, 2010
openaire   +1 more source